These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 22216957)

  • 1. Clinical application of stem cell therapy in Parkinson's disease.
    Politis M; Lindvall O
    BMC Med; 2012 Jan; 10():1. PubMed ID: 22216957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ectopic dopaminergic progenitor cells from En1(+/Otx2lacZ) transgenic mice survive and functionally reinnervate the striatum following transplantation in a rat model of Parkinson's disease.
    Hackl C; Papazoglou A; Ganser C; Klein A; Prakash N; Wurst W; Nikkhah G
    Cell Transplant; 2010; 19(9):1085-101. PubMed ID: 20447348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell therapy for Parkinson's disease: Functional role of the host immune response on survival and differentiation of dopaminergic neuroblasts.
    Wenker SD; Leal MC; Farías MI; Zeng X; Pitossi FJ
    Brain Res; 2016 May; 1638(Pt A):15-29. PubMed ID: 26239914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interrogating the aged striatum: robust survival of grafted dopamine neurons in aging rats produces inferior behavioral recovery and evidence of impaired integration.
    Collier TJ; O'Malley J; Rademacher DJ; Stancati JA; Sisson KA; Sortwell CE; Paumier KL; Gebremedhin KG; Steece-Collier K
    Neurobiol Dis; 2015 May; 77():191-203. PubMed ID: 25771169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine release from transplanted neural stem cells in Parkinsonian rat striatum in vivo.
    Kang X; Xu H; Teng S; Zhang X; Deng Z; Zhou L; Zuo P; Liu B; Liu B; Wu Q; Wang L; Hu M; Dou H; Liu W; Zhu F; Li Q; Guo S; Gu J; Lei Q; Lü J; Mu Y; Jin M; Wang S; Jiang W; Liu K; Wang C; Li W; Zhang K; Zhou Z
    Proc Natl Acad Sci U S A; 2014 Nov; 111(44):15804-9. PubMed ID: 25331880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural Stem Cells Derived from Human Parthenogenetic Stem Cells Engraft and Promote Recovery in a Nonhuman Primate Model of Parkinson's Disease.
    Gonzalez R; Garitaonandia I; Poustovoitov M; Abramihina T; McEntire C; Culp B; Attwood J; Noskov A; Christiansen-Weber T; Khater M; Mora-Castilla S; To C; Crain A; Sherman G; Semechkin A; Laurent LC; Elsworth JD; Sladek J; Snyder EY; Redmond DE; Kern RA
    Cell Transplant; 2016 Nov; 25(11):1945-1966. PubMed ID: 27213850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cells for cell therapy in Parkinson's disease.
    Lindvall O
    Pharmacol Res; 2003 Apr; 47(4):279-87. PubMed ID: 12644384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell therapy in Parkinson's disease.
    Lindvall O; Björklund A
    NeuroRx; 2004 Oct; 1(4):382-93. PubMed ID: 15717042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural grafting in Parkinson's disease Problems and possibilities.
    Brundin P; Barker RA; Parmar M
    Prog Brain Res; 2010; 184():265-94. PubMed ID: 20887880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Birth dating of midbrain dopamine neurons identifies A9 enriched tissue for transplantation into parkinsonian mice.
    Bye CR; Thompson LH; Parish CL
    Exp Neurol; 2012 Jul; 236(1):58-68. PubMed ID: 22524988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards a Better Treatment Option for Parkinson's Disease: A Review of Adult Neurogenesis.
    Farzanehfar P
    Neurochem Res; 2016 Dec; 41(12):3161-3170. PubMed ID: 27613619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural transplantation: a hope for patients with Parkinson's disease.
    Lindvall O
    Neuroreport; 1997 Sep; 8(14):iii-x. PubMed ID: 9331903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging restorative treatments for Parkinson's disease: manipulation and inducement of dopaminergic neurons from adult stem cells.
    Zhao J; Xu Q
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):509-16. PubMed ID: 21495964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for bringing stem cell-derived dopamine neurons to the clinic: A European approach (STEM-PD).
    Kirkeby A; Parmar M; Barker RA
    Prog Brain Res; 2017; 230():165-190. PubMed ID: 28552228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells.
    Isacson O; Bjorklund LM; Schumacher JM
    Ann Neurol; 2003; 53 Suppl 3():S135-46; discussion S146-8. PubMed ID: 12666105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
    Chen W; Huang Q; Ma S; Li M
    ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease.
    Cova L; Armentero MT; Zennaro E; Calzarossa C; Bossolasco P; Busca G; Lambertenghi Deliliers G; Polli E; Nappi G; Silani V; Blandini F
    Brain Res; 2010 Jan; 1311():12-27. PubMed ID: 19945443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease.
    Lindvall O; Kokaia Z
    Trends Pharmacol Sci; 2009 May; 30(5):260-7. PubMed ID: 19362379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on fetal transplantation: the Swedish experience.
    Lindvall O
    Mov Disord; 1998; 13 Suppl 1():83-7. PubMed ID: 9613723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cells and cell replacement therapy for Parkinson's disease.
    Sonntag KC; Simunovic F; Sanchez-Pernaute R
    J Neural Transm Suppl; 2009; (73):287-99. PubMed ID: 20411787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.